Tokyo/new York

For Tokyo/new York's latest contributions to The Japan Times, see below:

Challenges await Takeda after $62 billion Shire victory

/ | May 9, 2018

Challenges await Takeda after $62 billion Shire victory

Takeda Pharmaceutical Co.'s Chief Executive Officer Christophe Weber navigated rebuffs, critics and a plunging stock price to win a $62 billion (¥6.8 trillion) deal to acquire larger rival Shire Plc. Integrating the Japanese drugmaker — which began by selling herbal therapies 237 years ago — ...